MoneyWorks4Me

Jenburkt Pharmaceuticals informs about board meeting intimation

16 May 2022 Evaluate

Jenburkt Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022, to consider and approve audited standalone financial results for the quarter and financial year ended on 31.03.2022 and to consider the recommendation of dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..